Page 809 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 809

INDEX                                                                                        INDEX                     765




                  Diuresis                   Dorsal columns (spinal cord), 508,   multiorgan, 251  Dyskinesia
                    atrial natriuretic peptide, 296  509                 musculoskeletal, 250       tardive, 251
                    for shock, 310             thalamic relay for, 498   neurologic, 251          Dyslipidemia
                  Diuretics                  Dorsal interossei muscle, 450  renal/genitourinary, 251  β-blocker adverse effects, 323
                    dilated cardiomyopathy, 308  Dorsal motor nucleus, 506  respiratory, 251        β-blockers, 245
                    electrolyte changes, 609  Dorsal optic radiation, 542  Drug reaction with eosinophilia   familial, 94
                    glaucoma treatment, 552  Dorsal pancreatic bud, 360       and systemic symptoms   renal failure and, 603
                    hypertension treatment, 316  Dorsiflexion                 (DRESS), 250          vitamin B  for, 67
                                                                                                          3
                    magnesium levels and, 332  common peroneal nerve injury,   Drug-related disorders  Dysmenorrhea
                    mechanism and clinical use, 607  453                 myocarditis, 313           copper IUD, 657
                    pancreatitis, 249        Dosage calculations, 231   Drug resistance             primary, 645
                    for SIADH, 338           Dosage interval, 231        plasmids in, 131         Dysmetria
                  Diverticula, 383           Double-blinded studies, 256  Drugs                     central vertigo, 534
                  Diverticulitis, 383        Double stranded viruses, 163  cholinomimetic agents, 240  with strokes, 514
                  Diverticulosis, 383        Double Y males, 638         efficacy vs potency, 233  Dyspareunia, 567
                  Diverticulum, 383          Down syndrome, 63           elimination of, 232, 233  Dysphagia
                  Dizygotic (“fraternal”) twins, 616  ALL and AML in, 432  errors in, 274           achalasia, 376
                  Dizziness                    cardiac defect association, 300  patient difficulty with, 268  esophageal pathologies and,
                    AChE inhibitors, 549       cataracts and, 535        phase I metabolism, 232        377–378
                    calcium channel blockers, 318  chromosome association, 64  reactions to, 248–251  in botulism, 138
                    dihydropyridine, 318       hCG in, 633               therapeutic index, 234     osmotic demyelination syndrome,
                    nitrates, 318              Hirschsprung disease and, 384  toxicities, 248           524
                    ramelteon, 547             intestinal atresia and, 359  Drug safety             Plummer-Vinson syndrome, 418
                    ranolazine, 319          Doxazosin, 244              therapeutic index, measurement,   stroke effects, 514
                    sacubitril, 319          Doxepin, 575                     234                   Zenker diverticulum, 384
                    vertigo and, 534         Doxorubicin                Drug trials, 256          Dysplasia
                  DMPK gene, 61                dilated cardiomyopathy, 248  Drunken sailor gait, 511  bronchopulmonary, 210
                  DNA                          targets, 438             Drusen, 536                 cellular adaptive response, 206
                    cloning methods, 55        toxicities, 444          Dry beriberi, 66            cervical, 645
                    free radical effect on, 210  Doxycycline            Dry cough with ACE inhibitors, 251  neoplastic progression, 219
                    introns vs exons, 43       chlamydiae, 148          Dry mouth                 Dysplastic kidney
                    laddering in apoptosis, 208  in gonorrhea treatment, 142  Lambert-Eaton myasthenic   multicystic, 578, 579
                    methylation in, 34         lymphogranuloma venereum, 149  syndrome, 472       Dyspnea
                    mutations in, 39           MRSA, 198                Dry skin, 66                α -antitrypsin deficiency, 392
                                                                                                     1
                    plasmid transfer, 130      Mycoplasma pneumoniae, 150  Dubin-Johnson syndrome, 393, 394  aortic stenosis, 291
                    repair of, 40              rickettsial/vector-borne disease,    Duchenne muscular dystrophy, 61  heart failure, 309
                  DNA ligase                       150                   inheritance, 61            hypersensitivity pneumonitis, 675
                    action of, 38              tetracyclines, 192       Ductal adenocarcinomas, 368  hypertrophic cardiomyopathy, 308
                  DNA mutations              Doxylamine, 686            Ductal carcinoma in situ (DCIS),   in botulism, 138
                    types of, 39             DPP-4 inhibitors, 353            650                   Wegener granulomatosis, 315
                  DNA polymerase inhibitors, 253  Dressler syndrome, 305, 307, 313  Ductal carcinomas (invasive), 650  Dystonia
                  DNA polymerases            DRESS syndrome, 250        Ductus arteriosus, 282, 619  acute, 241
                    action of, 38            Drooling treatment, 241    Ductus deferens             antipsychotics/antiepileptics, 569
                  DNA repair, 40             Drop metastases, 528        embryology, 622            benztropine for, 241
                  DNA replication, 38        Drop seizures, 517         Ductus venosus, 282         Lesch-Nyhan syndrome, 37
                  DNA topoisomerases, 38     Drug dosages, 234          Duloxetine, 575             movement disorders, 519
                  DNA transcription            calculations, 231        Duodenal atresia, 359       nigrostriatal pathway and, 499
                    deacetylation, 34          lethal median, 234       Duodenal ulcer, 380         treatment of, 241
                  DNA viruses, 164             liver disease, 231       Duodenum                  Dystrophic calcification, 211, 227
                    characteristics, 163       loading, 231              basal electric rhythm, 362  Dystrophin gene, 61
                    genomes, 163               maintenance dose, 231     biliary structures and, 368  Dysuria, 654
                  Dobutamine, 242              median effective, 234     histology of, 362          cystitis, 181
                  Dofetilide, 323              renal disease, 231        location, 360              urinary catheterization, 185
                  Dogs (disease vectors), 145, 149  toxic dose, 234      secretory cells, 373       UTIs causing, 600
                  Dolutegravir, 203          Drug elimination, 231      Duplex collecting system, 579
                  Dominant inheritance, 59   Drug-induced lupus, 250    Dural venous sinuses, 503  E
                  Dominant negative mutations, 57  Drug interactions    Dura mater, 496           Ear
                  Donepezil, 240, 549          additive, type, 235      Dwarfism                    pharyngeal pouch derivation, 621
                  Do not resuscitate (DNR) order, 266  antagonistic, type, 235  achondroplasia, 462  Eardrum, 533
                  Dopamine, 242                permissive, type 235     D-xylose test, 381        Early complement deficiencies (C1-
                    basal ganglia, 500         potentiation, type, 235  Dynein                          C4), 107
                    bupropion effect, 576      synergistic, type, 235    movement of, 48          Eating disorders
                    changes with disease, 495  tachyphylactic, type, 235  Dynein motors, 171        anovulation and, 645
                    function of, 328         Drug metabolism, 232       Dysarthria, 516             binge-eating disorder, 567
                    Huntington disease, 520    cytochrome P-450 dependent,    Friedreich ataxia as, 531  bulimia nervosa, 567
                    kidney functions and, 589      232                   in botulism, 138           characteristics of, 567
                    l-DOPA, 548, 549           geriatric patients in, 232  osmotic demyelination syndrome,   pica, 567
                    MAO inhibition, 549, 575  Drug name conventions, 253–255  524                 Eaton agar
                    Parkinson disease, 548   Drug overdoses             Dysbetalipoproteinemia, 94  culture requirements, 126
                    PCT secretion of, 589      of weak acids, 233       Dysentery                 Ebola virus, 167, 171
                    pheochromocytoma secretion, 350  of weak bases, 233  Entamoeba histolytica, 179  Ebstein anomaly, 281, 298, 300
                    vitamin B  and, 67       Drug reactions              Escherichia coli, 145      lithium side effect, 574
                          6
                  Dopamine agonists, 330, 339, 548  cardiovascular, 248  Shigella spp, 132, 144, 179  E-cadherin, 219, 474
                  Dopamine receptors, 238      endocrine/reproductive, 249  Dysfunctional uterine bleeding, 633  ECF
                  Dopaminergic pathways, 499   gastrointestinal, 249    Dysgerminoma, 647           body compartments of, 231
                  Dornase alfa (DNAse), 60     hematologic, 250         Dysgeusia, 71             Echinocandins, 200






          FAS1_2019_21_Index_749-806.indd   765                                                                        11/21/19   12:27 PM
   804   805   806   807   808   809   810   811   812   813   814